AKT (Protein Kinase B) Neurons

Migration, Crosslink

📖

AKT (Protein Kinase B) Neurons

active

wiki page Created: 2026-04-02T07:19:39 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-cell-types-akt-neurons

📖 Wiki Page

cell1550 wordssynced 2026-04-02

AKT (Protein Kinase B) Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">AKT (Protein Kinase B) Neurons</th>
</tr>
<tr>
<td class="label">Isoform</td>
<td>Expression Pattern</td>
</tr>
<tr>
<td class="label">AKT1</td>
<td>Ubiquitous, highest in cortex and hippocampus</td>
</tr>
<tr>
<td class="label">AKT2</td>
<td>Moderate, enriched in metabolic neurons</td>
</tr>
<tr>
<td class="label">AKT3</td>
<td>High in brain, development-critical</td>
</tr>
</table>

AKT (also known as Protein Kinase B, PKB) is a serine/threonine kinase that serves as a central node in cellular signaling networks governing cell survival, growth, metabolism, and synaptic plasticity. In neurons, AKT plays critical roles in development, plasticity, and neuroprotection, making it a key molecule in understanding [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurodegenerative disorders. [@brazil2019]

The AKT family consists of three isoforms (AKT1, AKT2, AKT3) with distinct but overlapping expression patterns in the brain. AKT1 is the most broadly expressed, AKT2 is enriched in metabolic tissues including brain, and AKT3 is highly expressed in neuronal tissue. Each isoform contributes to specific aspects of neural function, and their coordinated activity is essential for normal brain physiology. [@datta2017]

...

AKT (Protein Kinase B) Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">AKT (Protein Kinase B) Neurons</th>
</tr>
<tr>
<td class="label">Isoform</td>
<td>Expression Pattern</td>
</tr>
<tr>
<td class="label">AKT1</td>
<td>Ubiquitous, highest in cortex and hippocampus</td>
</tr>
<tr>
<td class="label">AKT2</td>
<td>Moderate, enriched in metabolic neurons</td>
</tr>
<tr>
<td class="label">AKT3</td>
<td>High in brain, development-critical</td>
</tr>
</table>

AKT (also known as Protein Kinase B, PKB) is a serine/threonine kinase that serves as a central node in cellular signaling networks governing cell survival, growth, metabolism, and synaptic plasticity. In neurons, AKT plays critical roles in development, plasticity, and neuroprotection, making it a key molecule in understanding [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurodegenerative disorders. [@brazil2019]

The AKT family consists of three isoforms (AKT1, AKT2, AKT3) with distinct but overlapping expression patterns in the brain. AKT1 is the most broadly expressed, AKT2 is enriched in metabolic tissues including brain, and AKT3 is highly expressed in neuronal tissue. Each isoform contributes to specific aspects of neural function, and their coordinated activity is essential for normal brain physiology. [@datta2017]

AKT signaling is activated by a wide range of extracellular signals, including neurotrophic factors ([BDNF](/proteins/bdnf-protein), [NGF](/proteins/ngf-protein), [GDNF](/proteins/gdnf-protein)), insulin, and cellular stress responses. This central position makes AKT a critical integrator of signals that determine neuronal fate—survival versus death, growth versus atrophy, plasticity versus rigidity.

Overview

AKT is activated through a well-characterized PI3K-dependent pathway:

Receptor Activation: Growth factor receptors (TrkA, TrkB, Insulin receptor) become activated by ligand binding

PI3K Activation: Activated receptors recruit and activate phosphoinositide 3-kinase (PI3K)

PIP3 Production: PI3K generates phosphatidylinositol (3,4,5)-trisphosphate (PIP3) at the plasma membrane

AKT Recruitment: AKT is recruited to the membrane through interaction with PIP3

Phosphorylation: PDK1 phosphorylates AKT at Thr308; mTORC2 phosphorylates AKT at Ser473

Full Activation: Double-phosphorylated AKT dissociates from the membrane to phosphorylate substrates

AKT phosphorylates over 100 known substrates, affecting diverse cellular processes including metabolism, protein synthesis, cell cycle regulation, and apoptosis. [@manning2020]

AKT Isoforms in the Brain

AKT Signaling in Neurodegenerative Disease

Alzheimer's Disease

AKT dysfunction is a hallmark of [Alzheimer's disease](/diseases/alzheimers-disease) pathology:

Amyloid-beta Effects: [Amyloid-beta](/proteins/amyloid-beta) oligomers impair AKT activation through multiple mechanisms
Insulin Resistance: AD brain shows reduced AKT signaling resembling insulin resistance
Tau Pathology: AKT-mediated phosphorylation of [GSK3β](/proteins/gsk3b-protein) affects [tau](/proteins/tau) phosphorylation
Synaptic Failure: AKT-dependent synaptic plasticity mechanisms are disrupted

The reduction in AKT signaling contributes to:

Increased neuronal apoptosis
Impaired synaptic plasticity and memory formation
Dysregulated glucose metabolism
Accelerated tau pathology [@rosenzweig2020]

Therapeutic Implications: AKT activators and PI3K agonists are being explored as potential AD treatments. However, the complexity of AKT signaling requires careful targeting to avoid adverse effects.

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), AKT signaling provides neuroprotection:

PINK1/Parkin Connection: AKT phosphorylates Parkin and enhances mitophagy
Mitochondrial Protection: AKT protects against mitochondrial dysfunction
Dopaminergic Neuron Survival: BDNF-mediated AKT activation supports dopamine neuron survival
Alpha-synuclein Interaction: AKT can phosphorylate [alpha-synuclein](/proteins/alpha-synuclein) and reduce its toxicity

Mutations in PINK1 and Parkin impair the protective effects of AKT signaling, making dopaminergic neurons more vulnerable to cellular stress. [@hao2019]

Amyotrophic Lateral Sclerosis

AKT dysregulation contributes to motor neuron degeneration in ALS:

Excitotoxicity triggers AKT-dependent cell death pathways
Mutant SOD1 impairs AKT survival signaling
Therapeutic targeting of AKT is under investigation

Traumatic Brain Injury

Following traumatic brain injury, AKT signaling plays complex roles:

Acute AKT activation is neuroprotective
Chronic dysregulation contributes to secondary damage
Targeting AKT may improve outcomes [@kumar2020]

Molecular Mechanisms

Cell Survival

AKT promotes neuronal survival through multiple mechanisms:

BAD Phosphorylation: AKT phosphorylates BAD, preventing it from inhibiting anti-apoptotic proteins

Caspase Inhibition: AKT indirectly inhibits caspases through multiple pathways

NF-κB Activation: AKT activates NF-κB, promoting expression of survival genes

FOXO Inactivation: AKT phosphorylates FOXO transcription factors, blocking pro-apoptotic gene expression

Synaptic Plasticity

AKT is critical for activity-dependent synaptic changes:

mTORC1 Activation: AKT activates mTORC1, driving local protein synthesis at synapses
AMPA Receptor Trafficking: AKT regulates AMPA receptor insertion and removal
Long-term Potentiation: AKT is required for LTP maintenance
Dendritic Spine Formation: AKT signaling controls spine morphogenesis [@zhao2019]

Metabolism

AKT integrates neuronal metabolism with survival:

Glucose Uptake: AKT stimulates glucose transporter (GLUT) trafficking to membranes
Glycogen Synthesis: AKT activates glycogen synthase
Lipid Metabolism: AKT regulates lipid synthesis and storage
Mitochondrial Function: AKT controls mitochondrial dynamics and quality control [@choi2020]

Autophagy and Mitophagy

AKT regulates cellular quality control mechanisms:

mTORC1 Inhibition: AKT activates mTORC1, which inhibits autophagy
TFEB Activation: AKT can promote TFEB nuclear translocation
PINK1/Parkin Pathway: AKT phosphorylates components of the mitophagy pathway
Lysosomal Function: AKT supports lysosomal biogenesis and function

Neurotrophic Factor Signaling

AKT serves as a key mediator of neurotrophic factor effects:

Brain-Derived Neurotrophic Factor (BDNF)

BDNF activates AKT through TrkB receptor signaling:

BDNF → TrkB → PI3K → AKT
AKT mediates BDNF's anti-apoptotic effects
AKT is required for BDNF-dependent synaptic plasticity
BDNF/TrK/AKT axis is impaired in AD [@liu2020]

Nerve Growth Factor (NGF)

NGF signaling through TrkA activates AKT in cholinergic neurons:

Critical for basal forebrain neuron survival
Impaired in Alzheimer's disease
Contributes to cholinergic degeneration

Glial Cell Line-Derived Neurotrophic Factor (GDNF)

GDNF protects dopaminergic neurons through AKT:

Essential for Parkinson's disease therapy
AKT mediates GDNF's anti-apoptotic effects
Potential for neuroprotective strategies

Therapeutic Targeting

Small Molecule Activators

Several approaches to activate AKT therapeutically:

PI3K Agonists: Direct PI3K activation increases AKT phosphorylation
Allosteric AKT Activators: Bind AKT to promote phosphorylation
mTORC2 Activators: Enhance AKT Ser473 phosphorylation

Disease-Specific Strategies

Alzheimer's Disease:

Insulin signaling enhancers (intranasal insulin)
PI3K-activating compounds
BDNF mimetics

Parkinson's Disease:

GDNF/BDNF delivery strategies
AKT-activating neuroprotective compounds
Mitophagy enhancers

Challenges

Isoform Specificity: Pan-AKT activation causes metabolic side effects
Feedback Loops: Complex signaling networks create compensatory mechanisms
Blood-Brain Barrier: Drug delivery to CNS is challenging
Timing: Acute vs. chronic activation has different effects

Experimental Models

In Vitro

Primary Neuronal Cultures: Cortical and hippocampal neurons for pathway studies
iPSC-Derived Neurons: Patient-derived neurons for disease modeling
Cell Lines: Neuronal cell lines (SH-SY5Y, PC12) for drug screening

In Vivo

Transgenic Mice: AKT isoform-specific knockouts and conditional mutants
Viral Vectors: AAV-mediated AKT expression or knockdown
Chemical Inhibitors: DREADD-based AKT modulation

Behavioral Tests

Morris Water Maze: Spatial memory testing
Novel Object Recognition: Hippocampus-dependent memory
Rotarod: Motor coordination and learning
Conditioned Place Preference: Reward learning

Cross-References

[PIK3CA](/genes/pik3ca) - Catalytic subunit of PI3K
[PDK1](/genes/pdk1) - Phosphoinositide-dependent protein kinase-1
[PTEN](/genes/pten) - Negative regulator of AKT signaling
[GSK3B](/proteins/gsk3b-protein) - AKT substrate with tau relevance
[mTOR](/mechanisms/mtor-signaling-neurodegeneration) - AKT downstream target

[PI3K/AKT/mTOR signaling](/mechanisms/mtor-signaling-neurodegeneration)
[Apoptosis pathways](/mechanisms/apoptosis-neurodegeneration)
[Synaptic plasticity](/mechanisms/synaptic-plasticity)
[Neurotrophin signaling](/mechanisms/neurotrophin-signaling)
[Insulin signaling in brain](/mechanisms/insulin-signaling-neurodegeneration)

[Alzheimer's disease](/diseases/alzheimers-disease)
[Parkinson's disease](/diseases/parkinsons-disease)
[Amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[Traumatic brain injury](/diseases/traumatic-brain-injury)
[Diabetes-associated cognitive decline](/diseases/diabetes-cognitive-decline)

Brain Atlas Resources

Allen Cell Type Atlas

[Cell Type Atlas](https://celltypes.brain-map.org/) - Neuronal cell type classifications
[AKT Expression](https://celltypes.brain-map.org/?searchTerm=AKT) - Cell type-specific expression

Allen Human Brain Atlas

[Human Brain Atlas](https://human.brain-map.org/) - Regional gene expression
[AKT Brain Expression](https://human.brain-map.org/microarray) - Region-specific data

BrainSpan Atlas

[BrainSpan](https://brainspan.org/) - Developmental expression patterns
[AKT Development](https://brainspan.org/states?searchTerm=AKT) - Developmental trajectory

External Links

[UniProt AKT1](https://www.uniprot.org/uniprot/P31749) - Protein information
[Cell Signaling Technology AKT Pathway](https://www.cellsignal.com/) - Pathway resources
[KEGG AKT Signaling](https://www.kegg.jp/kegg/pathway/map04150.html) - Pathway maps

Background

The discovery of AKT (originally named v-AKT due to its discovery as an oncogene in transforming retrovirus AKT8) dates to the 1970s. Subsequent research revealed its role as a central signaling hub with profound implications for cell biology and disease.

Key milestones in understanding AKT in neurons:

1990s: Identification of AKT as a major survival signal
2000s: Discovery of AKT's role in synaptic plasticity
2010s: Understanding of AKT dysregulation in neurodegeneration
2020s: Therapeutic targeting efforts and precision medicine approaches

The complexity of AKT signaling, with its multiple isoforms, substrates, and regulatory mechanisms, presents both challenges and opportunities for developing neuroprotective therapies. As our understanding deepens, AKT remains a compelling target for treating neurodegenerative diseases.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Brazil et al., AKT signalling in health and disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31434919/)

[Datta et al., AKT and neurobiology (2017)](https://pubmed.ncbi.nlm.nih.gov/)

[Manning & Cantley, AKT/PKB signaling: navigating downstream (2020)](https://pubmed.ncbi.nlm.nih.gov/33268865/)

[Yuan et al., AKT in neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/)

[Hao et al., AKT activation and neuroprotection in Parkinson's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/)

[Rosenzweig et al., PI3K/AKT pathway in Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32912452/)

[Kimelberg et al., AKT and astrocyte function in neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/)

[Cheng et al., AKT/GSK3beta signaling in tauopathy (2021)](https://pubmed.ncbi.nlm.nih.gov/33846789/)

[Ma et al., mTORC1 and AKT in neuronal metabolism (2019)](https://pubmed.ncbi.nlm.nih.gov/)

[Kumar et al., AKT in traumatic brain injury (2020)](https://pubmed.ncbi.nlm.nih.gov/)

[Choi et al., Insulin resistance and neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/)

[Griffin et al., Phosphoinositide signaling in synapse function (2021)](https://pubmed.ncbi.nlm.nih.gov/)

[Park et al., PINK1-Parkin mitophagy and AKT (2019)](https://pubmed.ncbi.nlm.nih.gov/)

[Liu et al., Neurotrophin-mediated AKT activation (2020)](https://pubmed.ncbi.nlm.nih.gov/)

[Zhao et al., AKT and synaptic plasticity (2019)](https://pubmed.ncbi.nlm.nih.gov/)

📖 View canonical wiki page →

Related Entities

cell-types-akt-neurons

▸Metadataorigin_type: v1_polymorphic_backfill

slug	cell-types-akt-neurons
kg_node_id	None
entity_type	cell
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-6908e5c57086
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'cell-types-akt-neurons'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

34

Outgoing

47

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

AKT (Protein Kinase B) Neurons

AKT (Protein Kinase B) Neurons

Introduction

AKT (Protein Kinase B) Neurons

Introduction

Overview

AKT Isoforms in the Brain

AKT Signaling in Neurodegenerative Disease

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Traumatic Brain Injury

Molecular Mechanisms

Cell Survival

Synaptic Plasticity

Metabolism

Autophagy and Mitophagy

Neurotrophic Factor Signaling

Brain-Derived Neurotrophic Factor (BDNF)

Nerve Growth Factor (NGF)

Glial Cell Line-Derived Neurotrophic Factor (GDNF)

Therapeutic Targeting

Small Molecule Activators

Disease-Specific Strategies

Challenges

Experimental Models

In Vitro

In Vivo

Behavioral Tests

Cross-References

Brain Atlas Resources

Allen Cell Type Atlas

Allen Human Brain Atlas

BrainSpan Atlas

External Links

Background

References

💬 Discussion

📗 Cite This Artifact

AKT (Protein Kinase B) Neurons

AKT (Protein Kinase B) Neurons

Introduction

AKT (Protein Kinase B) Neurons

Introduction

Overview

AKT Isoforms in the Brain

AKT Signaling in Neurodegenerative Disease

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Traumatic Brain Injury

Molecular Mechanisms

Cell Survival

Synaptic Plasticity

Metabolism

Autophagy and Mitophagy

Neurotrophic Factor Signaling

Brain-Derived Neurotrophic Factor (BDNF)

Nerve Growth Factor (NGF)

Glial Cell Line-Derived Neurotrophic Factor (GDNF)

Therapeutic Targeting

Small Molecule Activators

Disease-Specific Strategies

Challenges

Experimental Models

In Vitro

In Vivo

Behavioral Tests

Cross-References

Related Genes and Proteins

Related Mechanisms

Related Diseases

Brain Atlas Resources

Allen Cell Type Atlas

Allen Human Brain Atlas

BrainSpan Atlas

External Links

Background

References

💬 Discussion